Discover the complete list of Active Pharmaceutical Ingredients (APIs) manufactured or distributed by GW Pharma Ltd. View detailed product information, certifications, and sourcing options for each API. Connect with GW Pharma Ltd for compliant, high-quality pharmaceutical ingredients trusted by global clients.
Country: United Kingdom
Supplier Description: GW Pharmaceuticals (GW Pharma) was a pioneering UK biopharma company, founded in 1998, specializing in cannabinoid-based medicines, known for Epidiolex (epilepsy) and Sativex (MS spasticity), and was acquired by Jazz Pharmaceuticals in 2021, becoming a key part of their neuroscience portfolio. GW Pharma developed treatments from cannabis, focusing on severe conditions like childhood epilepsy and multiple sclerosis, establishing itself as a leader in plant-derived therapeutics before its acquisition
